Pharma Pixelbay Courtesy: Pixabay
21 October 2015

Will the TPP impact Indian pharma?

Do the TPP and the proposed India-EU trade deal extend protection of IPR, delaying generic competition for life-saving drugs and keeping their prices high? While these and other possible implications for Indian consumers and pharma companies become clearer over time, India must robustly engage with the debate on trade deals and public interest

India’s First Think20 Meeting
21 October 2015

India’s First Think20 Meeting

On 19 October 2015, India's first Think20 (T20) regional consultation on "Turkey, India and the G20" brought together think tank experts from Turkey, China, India and Australia, business leaders from India and diplomatic representatives from the G20 countries to discuss issues concerning the G20.